Chemomab Therapeutics (CMMB) Share-based Compensation (QoQ) (2018 - 2023)
Chemomab Therapeutics (CMMB) Share-based Compensation (QoQ) (2018 - 2023) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Chemomab Therapeutics | 124.14 Mn | 113.77 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 83.08% |
| Sep 30, 2023 | -79.66% |
| Jun 30, 2023 | 32.02% |
| Mar 31, 2023 | 119.72% |
| Dec 31, 2022 | -393.54% |
| Sep 30, 2022 | 9.86% |
| Jun 30, 2022 | -12.93% |
| Mar 31, 2022 | 231.23% |
| Dec 31, 2021 | -251.02% |
| Sep 30, 2021 | -16.32% |
| Jun 30, 2021 | 1,125.58% |
| Mar 31, 2021 | -68.38% |
| Dec 31, 2020 | 491.30% |
| Sep 30, 2020 | -17.86% |
| Jun 30, 2020 | -39.13% |
| Mar 31, 2020 | -48.31% |
| Dec 31, 2019 | -72.27% |
| Sep 30, 2019 | -12.77% |
| Jun 30, 2019 | -3.16% |
| Mar 31, 2019 | 4.40% |